Home
About us
Industry +
News Room +
Contact usGlobal Cardiovascular Devices Market, Sales Analys...
RD Code : 53427Global Cardiovascular Devices Market, Sales Analysis, Market Revenue, Industry Drivers & Opportunities, Recent Trends & Developments, COVID-19 Impact, Regional Outlook, and Forecast 2022 – 2030, By Device Type (Diagnostic & Monitoring and Therapeutic & Surgical Devices); By Application (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, and Others); By End User (Hospitals, Specialty Clinics, Others); and Region (North America, Europe, Asia Pacific, South America, and Middle East and Africa)
Categories: Medical Devices & Consumables
Format : 
Market Outlook
According to Future Market Consulting analysis, Cardiovascular Devices Market size was valued at USD 53.45 Billion in 2021 and is projected to reach USD 91.22 Billion by 2030, growing at a CAGR of 6.3% from 2022 to 2030.
The global prevalence of ongoing cardiovascular diseases is substantially driving the worldwide cardiovascular devices market. The WHO states that cardiovascular disease is the primary cause of death worldwide. Cardiovascular disorders kill approximately 17.9 million people worldwide each year. High salt consumption in the diet, increased tobacco usage, rising smoking prevalence, and increased alcohol consumption are the key causes of cardiovascular disease. Cardiovascular illnesses can be efficiently treated if detected early. As a result, increased demand for early detection of cardiovascular disease is likely to fuel growth in the worldwide cardiovascular devices market.
Additionally, an alarming rise in physical inactivity and obesity is escalating the threats of heart disease, which is predicted to increase demand for cardiovascular devices on global scale. Another crucial aspect driving market expansion is the world's growing geriatric population. The growing need for efficient and novel cardiovascular devices to prevent cardiovascular disease-related fatalities is propelling the worldwide cardiovascular devices market forward. Furthermore, the incorporation of cutting-edge biotech advances in AI & ML in cardiovascular devices is increasing patient care services and lowering cardiac patient mortality.
Market Dynamics
Drivers
- Growing convenience towards healthcare services and steadily increasing cost - effectiveness of treatments.
- With the provision of advanced and developed healthcare infrastructure, patients adopt modern medical equipment at a higher rate.
Challenges
- Limitations in research & developments activities & lower production capacity
- Strict compliance of regulatory policies for launching new product
Key Players
- B Braun Melsungen AG
- Abbott
- Johnson & Johnson Services, Inc.
- Medtronic
- Boston Scientific Corporation
- LivaNova Plc
- Edwards Lifesciences Corporation
- GE Healthcare
- Siemens Healthcare GmbH
- Terumo Cardiovascular Systems Corporation
|
Report Attributes |
Details |
|
Market Size Value In 2021 |
USD 53.45billion |
|
Revenue Forecast In 2030 |
USD 91.22 billion |
|
CAGR |
6.3% from 2022 - 2030 |
|
Base Year |
2021 |
|
Historical Data |
2018 - 2020 |
|
Forecast Period |
2022 - 2030 |
|
Segments Covered |
By Device Type (Diagnostic & Monitoring and Therapeutic & Surgical Devices); By Application (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, and Others); By End User (Hospitals, Specialty Clinics, Others); |
|
Regional Scope |
North America (US, Canada, Mexico); Europe (UK, Germany, France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific); Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa); South America (Brazil, Argentina, Rest of South America); |
|
Key Companies |
B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Medtronic, Boston Scientific Corporation, LivaNova Plc, Edwards Lifesciences Corporation, GE Healthcare, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation |
Segment Insights
- Based on Device Type, Therapeutics and surgical devices dominated the market in 2021, accounting for 76% of total sales due to an increase in amount of bypass surgeries performed around the world. The rising demand for cardiac arrhythmia control units, catheters, and stents has boosted this segment's revenue creation. The segment's rise has been aided by growing awareness of cardiovascular diseases and the easy availability of equipment.
- Moreover, Diagnostic and monitoring is expected to become the most lucrative category during forecast period. The growing demand for early detection of cardiovascular illnesses is driving the expansion of this segment. The growing public awareness of the benefits of early diagnosis of CVDs and the availability of effective therapy are driving the expansion of the diagnostic and monitoring segment.
- In 2021, a coronary artery diseases sector dominated the worldwide cardiovascular devices segment based on application. The rising prevalence of coronary artery disorders has boosted market sales of coronary stents. The growing use of stent mostly in therapy of coronary artery diseases is projected to keep the market leader in place.
Recent Developments
- Feb’21 - Remo Care Solutions has unveiled a new AI-powered remote monitoring gadget for cardiac patients that monitors the patients’ health in real time.
- Dec’20 - BioTelemetry, Inc. was acquired by Philips to connect Philips' patient monitoring services with BioTelemetry's cardiac diagnosis and monitoring services in hospitals.
Regional Insights
- In 2021, North America dominated the worldwide cardiovascular devices market. The presence of numerous top manufacturers across the region, combined with the rising incidence of cardiac diseases in the United States, is growing rapidly for cardiovascular devices throughout the region. North America's technologically advanced healthcare infrastructure, combined with improved healthcare policies, has increased demand for different diagnostic instruments and surgeries.
- During the projection period, Asia Pacific is expected to witness significant growth in the market owing to their vast populace, rising occurrence of cardiovascular illnesses, expanding healthcare spending, and rising government investments in the development of advanced healthcare infrastructure.
Segmentation
By Device Type
- Diagnostic & Monitoring
- ECG
- Holter Monitors
- Event Monitors
- Implantable Loop Recorders
- Echocardiogram
- Pet Scan
- MRI
- Cardiac CT
- Doppler Fetal Monitors
- Therapeutic & Surgical Devices
- Pacemakers
- Stents
- Catheters and accessories
- Guidewires
- Cannulae
- Electrosurgical Procedures
- Valves
- Occlusion Devices
- Others
By Application
- Cardiac Arrhythmia
- Coronary Artery Disease
- Heart Failure
- Others
By End User
- Hospitals
- Specialty Clinics
- Others
By Region
- South America (Brazil, Argentina, Rest of South America);
- North America (US, Canada, Mexico);
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe);
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific);
- Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa);
Base Year:2021
Historical Data:2018 To 2020
No of Pages:
Select Licence Type
Single User
US$ 4500Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.
Multi User
US$ 6200Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.
Corporate User
US$ 9500The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.
Future Market Consulting is a research-based management consulting company that provides strategic advice to help clients on critical business perspectives: strategy, marketing organization operations and technology transformation.
Quick Links
Newsletter Subscription
Get the latest market news & updates at your inbox.
